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ABSTRACT

INTRODUCTION

Background: The Centers for Medicare and Medicaid
(CMS) has begun mandating infection surveillance at
surgical sites, which started in hospitals and is now
in ambulatory surgical centers (ASCs). We found a
0.1% increase in infection rate between 2005 and
2007, which prompted us to examine the issue further.
The purpose of the current study was to summarize
the results of an investigation after an outbreak of
infection at our ASC, specifically attempting to identify
a common pathogen, vector, or unknown lapses
in infection prevention. Additionally, we relate our
experience to current trends in infection prevention
at ASCs by examining the most recent CMS infection
surveillance requirements.
Methods: We performed a retrospective review of
patients with infections after orthopaedic procedures
at our ASC from 2005 to 2008. Infections were
identified by the Centers for Disease Control and
Prevention surveillance definitions, with a total of 17
patients included in the study. We also reviewed the site
inspection and documented the resultant interventions.
Results: No common pathogen was found in the
17 patients. The results of the site review noted a
contaminated tendon-stripper used in half of the cases,
poor disassembly of instruments before cleaning,
overuse of “flash” sterilization, and poor ventilation in
the operating suites. In 2011, infection rates returned
to 1.3%.
Conclusions: An ongoing infection surveillance
program, periodic site inspections, and process reviews
are essential to prevent surgical site infections at ASCs.

According to the Centers for Medicare and Medicaid
Services (CMS), an ambulatory surgical center (ASC) is
defined as: “a distinct entity that operates exclusively
for the purpose of providing surgical services to patients
not requiring hospitalization and in which the expected
duration of services would not exceed 24 hours following
an admission.”1 As of 2010, there were 5316 Medicarecertified ASCs, representing more than a 54% increase
from 2001. In 2007, an estimated 6 million surgical
procedures were performed at ASCs, with a $3 billion
cost to Medicare.2 As the number of ACSs and number
of procedures continues to grow, few data are available
regarding the complications of procedures performed in
these settings, specifically surgical site infections (SSIs).
To participate in the CMS “Pay for Performance”
program beginning January 2012, acute care
hospitals were required to perform surveillance on
SSIs (specifically infections in patients undergoing
colectomies and abdominal hysterectomies) and enter
the data into the National Healthcare Safety Network,
a secure database of the Centers for Disease Control
and Prevention (CDC).3,4 Although currently voluntary,
surveillance and data entry efforts are anticipated to
extend to more procedures and settings such as ASCs.
SSI rates after outpatient orthopaedic procedures tend
to be less than 1%.5-15 Some studies have reported a lower
SSI rate at single-specialty ASCs.16 A 2010 article from
Edmonston and Foulkes17 reviewed more than 11,000 cases
during a 5-year period at a single orthopaedic ASC. They
found the overall infection rate to be 0.33%. Infection rates
after anterior cruciate ligament (ACL) reconstructions
are estimated to be between 0.14% to 0.78%.10 Similarly,
infection rates after orthopaedic arthroscopic procedures
are estimated to be between 0.10% to 1.1%.7,18
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Figure 1. Arthroscopic and anterior cruciate ligament
(ACL) infection rates between 2005 to 2008.
At our inpatient institution, SSI surveillance began in
2003 and has evolved from a retrospective review of
single procedures to a prospective program of multiple
procedures. In 2005, surveillance was expanded
to include our affiliated ASC. There was a noted
increase in postoperative infections after outpatient
orthopaedic procedures seen in the Outpatient
Parenteral Antimicrobial Therapy Clinic. Because of
this, surveillance on orthopaedic SSIs was instituted
for ACL reconstructions and eventually expanded to
include all arthroscopic knee and shoulder procedures.
Retrospective review of orthopaedic SSIs between
2005 and 2008 indicated an increased infection rate of
2.5% in 2005 and 2.6% in 2007 (Figure 1). These results
prompted an outbreak investigation at the facility to
determine if there was a common pathogen or vector
contributing to the increased infection rate.
The purpose of this paper was to first summarize
the results of the outbreak investigation, specifically
looking for a common pathogen, vector, or other lapse
in infection control. Secondly, we wanted to relate
our experience to current requirements in infection
prevention at ASCs, referencing the most recent
“Guidance for Surveyors” document for ASCs from CMS.17

METHODS
We received approval from our Human Research Review
Committee (HRRC #19-127). With the assistance of the
Division of Epidemiology, Biostatistics and Preventive
Medicine at The University of New Mexico Hospital,
we reviewed medical records of patients to determine
SSIs after orthopaedic procedures at our ASC between
May 2005 to December 2008. Specifically, we reviewed
medical records of patients with infections identified by
the hospital infection control program, which reviewed
all orthopaedic arthroscopic procedures performed
at our ACS. Ultimately, 17 patients were identified and
included in the study. Additionally, we completed a
review of the site inspection, resultant interventions, and
infection rates all through 2011.
Criteria for Surgical Site Infections
CDC surveillance definitions were used to identify SSIs.
At the time of our investigation, SSIs were defined as
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infections that occurred within 30 days of the index
procedure (with the exception of procedures involving
implants, which were monitored for 1 year).19 For this
investigation, surveillance was limited to organ space
SSIs which correlates to a clinical diagnosis of septic
arthritis. Diagnosis of an organ space SSI required at
least one of the following factors to be documented in
the medical records: purulent drainage from a drain that
is placed through a stab wound into the organ or space;
organisms isolated from an aseptically obtained culture
of fluid or tissue in the organ or space; an abscess or
other evidence of infection involving the organ or space
that is found on direct examination, during reoperation,
or by histopathological or radiological examination;
or diagnosis of an organ or space SSI by a surgeon or
attending physician.
Diagnosis of Septic Arthritis
Clinical diagnosis of septic arthritis is based on physical
examination findings such as joint swelling, warmth, or
positive joint aspiration.6 Other factors include pain,
difficulty, or inability to bear weight in conjunction
with elevated inflammatory markers during laboratory
examination.6 At our facility, we consider the following
levels to be elevated: erythrocyte sedimentation rate
(ESR), > 20 mm/hr; C-reactive protein (CRP), > 0.4
mg/dL; and white blood cell count (WBC), > 10.6 x
103 cells/mm3. There are two gold standards for the
diagnosis of septic arthritis. The first is a joint aspiration
with a positive gram stain or culture, and the second
is a total nucleated cell count greater than 50,000
WBC/mL in a native joint or greater than 2500 WBC/
mL in a prosthetic joint.6,20 Although a CDC definition
for septic arthritis has been developed along with
an orthopaedic definition for periprosthetic joint
infections, no surveillance definition specifically
addresses infections of arthroscopic joint infections.21
Notably, there is considerable morbidity with superficial
infections but we focused on the commonalities
between patients who had septic arthritis.
Data Gathered
We reviewed the ESR, CRP, WBC, and joint aspiration
results. Additionally, we collected data regarding
patient age, date of index procedure, preoperative
diagnosis, index procedure, graft used, number of
days from surgical procedure to diagnosis of infection,
subsequent procedures (ie, type and number), antibiotic
treatment (ie, type and duration), and preoperative
antibiotic administration.
We also examined infection control records on
facility inspections, findings, and interventions. In the
medical records, several aspects of patient care and
safe practices were evaluated on the basis of multiple
visits. These included patient preoperative preparation,
perioperative antibiotic administration, instrument
processing and sterilization, operating room ventilation,
and personnel adherence to the best infection control
practices.

Table 1. Age and diagnosis details of the 17 patients with surgical site infectionsa
Patient Age,
Years

Diagnosis

Surgical
Procedure

Graft

Days to
Infection

Laboratory Resultsb

Cultures Results

22

ACLt, MMt,

ACLr, MMd

BPTB
autograft

21

WBC, 7.4, ESR, 84
CRP, 25.7, TNC, 96,160

No growth

45

ACLt,
MCLt, PCLt,

ACLr, MCLr
PCLr

HS autograft
and allograft

29

WBC, 9.7, ESR, 123
CRP, 15.8, TNC, --

Pseudomonas aeruginosa,
Enterobacter cloacae,
Corynebacterium lipophiloflavum

19

ACLt

ACLr

HS autograft

19

WBC ,11.8, ESR, 73
CRP, --, TNC, 121,400

Staphylococcus
epidermidis

60

RCT, SLAP,
ACA

RCTr, SLAPr,
SAD,

--

14

WBC, 13.8, ESR, 56
CRP, 27, TNC, --

Methicillin-sensitive
Staphylococcus aureus

56

Shoulder
synovitis

Synovectomy

--

8

WBC, 14.3, ESR, 6
CRP, 2.8,, TNC, 57,000

Methicillin-sensitive
Staphylococcus aureus

15

ACLt

ACLr

HS autograft

26

WBC, 10.5, ESR, -CRP, 13.7, TNC, 38,000

Staphylococcus haemolyticusa

51

ACLt, MMt

ACLr, MMd

HS autograft

30

WBC, 7.7, ESR, 68
CRP, 1.4, TNC, 41,400

Staphylococcus epidermidis

21

ACLt, MMt,
LMt

ACLr, MMd,
LMd

HS autograft

25

WBC, 10.1, ESR, 90
CRP, 4.6, TNC, 80,840

Staphylococcus epidermidis

54

MMt

MMd

--

13

WBC, 7.0, ESR, 51
CRP, 11.3, TNC, 81,100

Enterococcus faecalis,
Staphylococcus capitisa

48

PLCi

PLCr

Achilles and
TA allografts

27

WBC, 8.2, ESR, 29
CRP, 9.5, TNC, 87,990

No growth

34

ACLt

ACLr

HS autograft

20

WBC, 9.7, ESR, 30
CRP, 3.6, TNC, 47,640

No growth

14

ACLt

ACLr

HS autograft

17

WBC, 7.9, ESR, 45
CRP, 6.4, TNC, 46,000

No growth

54

Loose
body

Loose body
removal

--

12

WBC, 8.8, ESR, 5
CRP, 2.6, TNC, 18,360

Enterobacter cloacae

29

ACLt, LMt

ACLr,
LM repair

HS autograft

140

WBC, 8.6, ESR, 107
CRP, 12.6, TNC, 73,370

No growth

19

Knee
synovitis

Synovectomy

--

14

WBC, 10.2, ESR, 44
CRP, 14.3, TNC, 73,370

Staphylococcus capitis, Staphylococcus
epidermidis, Corynebacterium

53

ACLt, MMt

ACLr, MMd

HS autograft

36

WBC, 7.3, ESR, 42
CRP, 11.5, TNC, 37,140

No growth

58

LMt

LMd

--

22

WBC, 6.3, ESR, 29
CRP, 3.8, TNC, 37,140

Staphylococcus epidermidis

ACA, acromioclavicular arthritis; ACLt, anterior cruciate ligament tear; ACLr, anterior cruciate ligament reconstruction; BPTB, bone-patellar tendonbone; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HS, hamstrings; MCLt, medial collateral ligament tear; MCLr, medial collateral
ligament reconstruction; MMd, medial meniscus debridement; MMr, medial meniscus repair; MMt, medial meniscus tear; LMd, lateral meniscus
debridement; LMr, lateral meniscus repair; LMt, lateral meniscus tear; PLCi, posterolateral corner injury; PLCr, posterolateral corner reconstruction;
RCRi, rotator cuff repair; RCRr, rotator cuff tear repair; SAD, subacromial decompression; SLAP, superior labrum anterior to posterior; TA, tibialis
anterior; TNC, total nucleated cells; WBC, white blood cell count; --, not applicable.
All patients diagnosed with septic arthritis had purulence in the joint with the exception of this patient who was diagnosed with a superficial wound
infection.
a
Considered to be contaminants.
b
At our facility, the following levels are elevated and suggestive of infection: erythrocyte sedimentation rate, > 20 mm/hr; C-reactive protein, > 0.4
mg/dL; white blood cell count (WBC), > 10.6 x 103 cells/mm3; and total nucleated cell count, > 50,000 WBC/mL.
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Figure 2. Pathogens by the number of cases and year between 2005 and 2008. GNR, gram
negative rods. MSSA, methicillin-sensitive Staphylococcus aureus. Staph Epi, Staphylococcus
epidermidis.

RESULTS
Table 1 shows patient demographics and diagnosis
details. Of the 17 patients, two had undergone shoulder
arthroscopies and 15 had undergone knee arthroscopies.
Of the 15 knee arthroscopies, there were nine ACL
reconstructions (ie, four meniscal debridements and
one meniscal repair), two meniscal debridements,
one multiligament reconstruction, one posterolateral
corner reconstruction, one loose body removal, and one
synovectomy. There were nine hamstring autografts,
one bone-patella tendon-bone autograft, and three
allografts used for reconstruction. Of the two patients
with shoulder arthroscopies, one involved a rotator
cuff and SLAP (ie, superior labral tear from anterior to
posterior) repair and the other involved synovectomy.
Diagnosis and Treatment
The average time to diagnosis and treatment of infection
was 28 days from the index procedure. One patient
who was identified with a late infection was treated at
140 days. Culture results were negative for infection in
6 of the 17 patients. The remaining patients developed
Staphylococcus epidermidis, multiple organisms,
methicillin-susceptible Staphylococcus aureus, and
gram-negative rods (Figure 2).
All patients were treated with irrigation and
debridement in the operative suite, with 16 of
the 17 patients treated arthroscopically and one
patient treated with open debridement. Subsequent
debridements were required for five patients. Hardware
and grafts were removed in three patients, and three
patients had antibiotic beads placed and subsequently
removed. Perioperative antibiotics were given to 14
of the 17 patients. In 16 patients, septic arthritis was

66

SCIENTIFIC ARTICLES • UNMORJ VOL. 8 • 2019

treated with intravenous antibiotics. The two remaining
patients were treated with oral antibiotics. There
were various combinations of medications, route, and
duration of the treatments (Table 2).
Two surgeons performed 16 of the 17 index
procedures. The remaining index procedure was
performed by a different surgeon. It should be noted
that one surgeon performed six of the eight ACL
reconstructions that developed infection.
Infection Rates
Infection rates by year are reviewed in Figure 3. SSI
rates after all arthroscopic procedures from 2005 to
2011 were 0.81%, 0.91%, 0.73%, and 0.38% for each
sequential year. Infection rates after ACL reconstruction
were 2.5%, 1.6%, 2.6% and 1.3% for each sequential year.
Site Investigation Findings
Results of the site investigation revealed important
deficiencies in infection control, with most issues being in
sterile processing. On one site visit, positive airflow in the
operating rooms was found to be inadequate. Interviews
with the sterile processing department revealed a lack of
understanding of instrument disassembly and cleaning,
brushes being re-used and not cleaned, and employees
running short cycles during the pre-sterilization wash
process at the end of the day. At that time, none of the
sterilization technicians were certified.
Three patients did not receive perioperative antibiotics.
During the study period, a povidone-iodine mixture was
used for skin preparation on all patients. Additionally, a
tendon-stripper commonly used by the two surgeons in
this study was not being completely disassembled before
cleaning. After properly disassembling the tendon-stripper, it was found to have visible adherent debris.

Table 2. Treatment details of the 17 patients with surgical site infectionsa
No. postoperative procedures
and details

Antibiotic
treatment
(type, method)

Antibiotic duration,
weeks

Peri-op
antibiotic

22

1 - AD

Ceftriaxone IV Levofloxacin PO

5

Yes

45

3 - AD, HWR, GR,
antibiotic beads

Ciprofloxacin PO, Zosyn IV, Linezolid PO

18

Yes

19

3 – AD, GR, HWR,
antibiotic beads

Vancomyocin IV, Clindamycin IV,
Rifampin PO

8

Yes

Patient age,
years

60

3 – AD, antibiotics beads

Nafcillin IV, Rifampin PO, Linezolid PO

16

Yes

56

2 - AD

Cefazolin IV, Bactrim PO

6

Yes

15

1 – AD

Cephalexin PO

2

Yes

51

1 – AD

Nafcillin/Cefazolin IVb
Ciporofloxacin PO, Rifampin PO

18

Yes

21

1 – AD

Nafcillin IV

6

No

54

1 – AD

Ceftriaxone IV, Amoxicillin PO

5

No

48

1 – open I&D, HWR, GR

Linezolid PO

4

Yes

34

1 – AD

Vancomycin IV, Rifampin PO, Linezolid PO

6

No

14

1 – AD

Cefazolin IV

6

Yes

54

2 – AD

Vancomycin IV, Ciprofloxacin PO,
Rifampin PO, Linezolid PO

6

Yes

29

1 – AD

Vancomycin IV, Ciprofloxacin PO,
Rifampin IV

6

Yes

19

1 – AD

Nafcillin IV, Cephalexin PO

6

Yes

53

2 – AD

Linezolid PO

4

Yes

58

1 – AD

Vancomycin IV

4

Yes

AD, arthroscopic debridement; GR, graft removal; HWR, hardware removal; IV, intravenous; peri-op, perioperative; PO, oral.
a
All treated with repair/reconstruction, meniscal debridement, synovectomy or loose body removal as indicated by the diagnosis with the
exception of one who underwent lateral meniscal repair and anterior cruciate ligament reconstruction.
b
Increased creatinine, switched to Cefazolin.

DISCUSSION
Before the start of this study, we observed an increase
in orthopaedic SSIs at our ASC between 2005 and
2008 (ie, 2.5% in 2005 and 2.6% in 2007). Results
of a thorough review of medical records and a site
investigation indicated that most patients with
infections had undergone knee ligament reconstructive
procedures (primarily ACL reconstruction) performed
by two orthopaedic surgeons. Additionally, the SSIs
were likely the result of a lack of standardization in
sterile processing.
In the current study, there were 17 patients diagnosed
with deep SSI. Of these patients, nine received
hamstring autografts and four received hamstring
allografts. Although there is an increased risk of SSI
with both hamstrings autograft and allograft, our
infection rate was far greater than what could be
explained by graft choice alone.22 For reconstructions,
we used nine hamstring autografts, one bone-patella
tendon-bone autograft, and three allografts. Although
it appeared that the inappropriately handled tendonstripper may have contributed to some of the infections,
there was no common infectious agent found indicating
one source. Additionally, the povidone-iodine mixture

used on all patients primarily used for skin preparation.
One prospective randomized controlled study found
that a chlorhexidine-alcohol mixture is superior to
iodine for prevention of SSIs; however, these findings
have not yet been incorporated into formal guidelines.23
Among our patients with negative culture findings,
there was a low-grade yet persistent inflammatory
reaction. It was suggested that it may have been
a reaction to the sterile debris in contaminated
instruments.
Healthcare-associated infections are a leading
cause of death in the United States, with an estimated
1.7 million healthcare-related infections and 99,000
deaths attributed to these infections in 2002.23,24 These
data, however, do not reflect the burden of infections
acquired in ambulatory settings and day-time surgical
procedures. In response to the growing concerns
surrounding healthcare-associated infections, the United
States Department of Health and Human Services
released an action plan in January 2009 to help prevent
healthcare-associated infections.24 The first phase
of recommendations focused on six related areas of
healthcare-associated infections such as SSIs at acute
inpatient facilities. However, it did not focus on ASCs.
In 2008, an outbreak at one Nevada ASC prompted
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Figure 3. Arthroscopic infections by attending and type of case. ACL, anterior cruciate
ligament; Recon, reconstruction; Multi-Lig, multiligament.
an investigation into infection control at all 51 ASCs in
Nevada. The investigation used an audit tool developed
by the CDC25 and found lapses in infection control
in 28 of the ASCs. These findings prompted CMS
to conduct further investigation in three additional
states (Maryland, North Carolina, and Oklahoma) and
found that 46 of the 68 facilities surveyed had at least
one major lapse in infection control.26 Subsequently,
the United States Department of Health and Human
Services recognized the need to address the prevention
of healthcare-associated infections. This therefore
led to the second phase of planning, which includes
the prevention of healthcare-associated infections
at ASCs.24 CMS current conditions of participation
include: an infection control program based on
nationally recognized infection control guidelines
that is under the direct control of trained infection
control personnel; integration of the infection control
program into the ASC’s quality improvement program;
and documentation that the ASC is controlling and
monitoring infections using this program.1
Infection surveillance at ASCs can pose particular
challenges. Post-discharge surveillance from ASCs
requires various methods of tracking patients (eg,
follow-up calls, surgeon surveys, and medical record
review).6 Unfortunately, high sensitivity is difficult to
achieve outside integrated healthcare systems with
common electronic records.27 Patients with infections
are typically admitted for diagnosis, debridement,
and initiation of antimicrobial therapy at acute care
facilities. Yet, there is a lack of communication in acute
care facilities that makes identifying cases difficult.
Therefore, a good working relationship with infection
professionals in local acute care hospitals is essential.
In some states, such as Texas, acute care hospitals
are required to notify the originating facility when
any patient is found to have a healthcare-associated
infection, which is now a requirement for acute care
facilities due to efforts by the Joint Commission.16,28
In response to the observed infection outbreak
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at our ASC, several changes were enacted. First, the
ventilation system was updated. Additionally, the
sterile processing technicians are now certified and all
instrumentation assembly and disassembly instructions
are readily available in the processing room. A continuous
improvement program is in place for immediate-use
sterilization (previously known as “flash” sterilization).
Furthermore, we continued to perform prospective
surveillance on all arthroscopic procedures performed in
our ASC; notably, this ended in 2011 when a temporary
reallocation of resources was required by new CMS
requirements and a change in the electronic health record.
The current study is a retrospective review and
therefore has some inherent limitations. First, there
is the potential of selection bias. The patients were
identified by medical records, and thus accuracy of
report was dependent on the clinical notes. Also,
the patients who experienced SSIs did return to our
healthcare system. It is possible that they sought
treatment for SSI elsewhere, but that was not noted
in the record. On the basis of these limitations, it is
impossible to draw definitive conclusions; however, this
review does give insights about the increased infection
rate that was found at our ASC.
Ultimately, our infections were recognized and
corrected because of a close partnership with infectious
diseases clinicians, our hospital epidemiologist, and
certified infection prevention specialists. ASCs may
require expert consultation to ensure that appropriate
infection surveillance and preventive processes are put
in place to meet the evolving standards of patient safety.
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